Effect of Laser Acupoints on Fallopian Tube Obstruction
For patients and families
In plain language
An automatic summary of structured registry data. It is an orientation aid, not a substitute for the official protocol or a physician assessment.
- What is being studied
- The protocol lists: Laser acupoints therapy + Standard care, Standard care.
- Who it may be relevant to
- Registry conditions: Laser, Acupoints, Fallopian Tube Obstruction. Basic parameters: 20 years — 35 years · Female.
- What needs checking
- Age, condition and sex are only basic indicators. Prior treatment, laboratory values and other mandatory requirements appear in the eligibility criteria below.
- Where it takes place
- Egypt
- Next step
- Save the trial, show it to the treating physician, and confirm current recruitment with the study center. Costs, documents and travel →
Unsure about the terms? Read our patient guide →
Overview
This study aims to determine the efficacy of laser acupoint therapy on treating fallopian tube obstruction.
Detailed description
Fallopian tube obstruction is a significant health concern that affects a substantial number of women worldwide, often leading to infertility and other reproductive issues. The fallopian tubes, essential components of the female reproductive system, play a crucial role in the process of conception by facilitating the transport of ova from the ovaries to the uterus.
The laser's focused light energy, when directed at specific acupoints linked to reproductive health, is hypothesized to activate the body's energy pathways or meridians, thereby facilitating healing and restoration of normal tubal function.
Although acupoint therapy shows promise, laser acupoint therapy offers potential advantages over traditional acupuncture by utilizing low-level lasers, which may enhance the treatment's efficacy. Laser acupoint therapy is noninvasive and painless, making it articularly appealing for patients who have a fear of needles or are sensitive to pain.
Interventions
- Other Laser acupoints therapy + Standard care
Patients will receive laser acupoints therapy addition to standard care. - Other Standard care
Patients will receive placebo laser acupoints therapy in addition to standard care.
Primary outcome measures
- Tubal patency [Time frame: 3 months post-treatment]
Secondary outcome measures (2)
- Anti-Müllerian Hormone (AMH) Test [Time frame: 3 months post-treatment]
- Quantitative Pregnancy Test [Time frame: 3 months post-treatment]
Eligibility criteria
Inclusion criteria
- Women aged 20-35 years - nulliparous.
- Women diagnosed with fallopian tube obstruction.
- Body mass index less than 30 kg/m2.
- Consent to participate in the study.
- General good health with no major co-existing medical conditions that could interfere with the treatment or outcomes.
- No prior fertility treatments \[e.g., In vitro fertilization (IVF), intrauterine insemination (IUI)\] within the last 6 months.
- Ability to attend all scheduled sessions and follow-up assessments.
Exclusion criteria
- Currently pregnant or breastfeeding.
- History of pelvic surgery within the past year.
- Presence of severe systemic diseases such as active cancer or severe cardiovascular diseases.
- History of allergic reactions or adverse responses to acupuncture or laser therapies.
- Currently undergoing hormonal therapy or use of hormonal contraceptives.
- Current or recent history of genital tract infections, including sexually transmitted. infections, which could affect the reproductive system.
- Presence of significant uterine anomalies diagnosed through imaging that could impact fertility.
- Polycystic Ovary Syndrome (PCOS).
Criteria are shown verbatim from the registry (in English). Final eligibility is always assessed by the study center.
Healthy volunteers: No
Study design
- Allocation
- Randomized
- Model
- Parallel assignment
- Masking
- Open label
- Primary purpose
- Treatment
Study locations
Egypt · 1 center
- Kafrelsheikh University (Faculty of Physical Therapy) — Kafr ash Shaykh
Identifiers
NCT: NCT07351747 · KFSIRB200-711